Abstract
To pharmaceutical industry, the ability of new product development is a very important index for the measurement of competition ability. From the beginning while there is only the ability to develop generic, then has the ability to develop Me-Too NCE, until where has the unique platform technology that enough to develop NCE, this is the goal that pharmaceutical factorys working hard. However, nowadays, pharmaceutical factorys in Taiwan still have no ability to development NCE, the reason is not because of the insufficient of technology, it is because of that pharmaceutical factorys in Taiwan do not have a complete and systematic process to development new products. Very different with other industrys, pharmaceutical industry pays much attention to the laws and patents. Its degree of complicacy is also different with other industry. So, it is very important to pharmaceutical industry to havs a complete and systematic process to development new products. Besides, the globalization is coming, although drug is a kind of product that is Acre-originated, and there is some entrance barrier, but foreign pharmaceutical factorys have more experiences and ability in development of NCE. This study first discusses the current situation of Taiwan’s pharmaceutical industry, and compares the view between pharmaceutical factorys and research organization, then builds a new product development process, checks and corrects this process by meeting with specialist and analyzing cases. The final objective is to help pharmaceutical factorys in Taiwan to develop new product better, and has a consultation to develop NCE.